Biocon Ltd has inaugurated its first US manufacturing facility in Cranbury, New Jersey, operated by its subsidiary, Biocon Generics Inc. Following the acquisition of the Oral Solid Dosage facility from Eywa Pharma Inc in 2023, Biocon invested over USD 30 million to establish the plant.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/r8AKiHu
via IFTTT
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
So I’m currently on a lean bulk on 2900 a day. And I wake up 6 am I have oats and protein powder or fruit then go gym around 9 am Then at ...
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2025
(576)
-
▼
September
(30)
- Cupid announces strategic investment in fragrance ...
- Biocon inaugurates first manufacturing facility in US
- Dr Reddy's inks pact with Johnson & Johnson to acq...
- Delhi HC stops drug body from taking action agains...
- Indian hospitals to raise IT innovation spend by 2...
- WHO adds popular weight-loss drugs to essential me...
- Medicines may soon come with braille labels, audio...
- Indian pharma sector needs price hikes, site and I...
- The missed window: Why half of India’s people with...
- Health experts alarmed by GST cut on beedis, deman...
- AstraZeneca to invest Rs 176 cr to expand GITC in ...
- USFDA issues Form 483 with 8 observations to Aurob...
- Glenmark initiates multi-nation Phase 3 clinical t...
- Type 2 diabetes triggering heart attacks in the 30...
- Pharma companies cheer lower drug prices, API tax ...
- GST cut on drugs, medical devices to provide relie...
- Crucial drugs to be more affordable after GST cut
- Centre set to amend rules to simplify drug testing...
- Alkem's Enzene powers into US with $70 m investment
- Singapore-based firm proposes to acquire 25% in We...
- Lupin gets USFDA nod for generic risperidone exten...
- Caplin Point arm gets USFDA nod for milrinone lact...
- Medical device manufacturers allowed to give free ...
- India eyes Russia, Brazil, Netherlands for pharma ...
- Glenmark launches generic cancer treatment drug in US
- Zydus launches VaxiFluTM trivalent influenza vacci...
- Fortis Healthcare arm inks 15-year lease with RR L...
- The #WeightofDiabetes iceberg: Why the real burden...
- Govt launches advanced biomanufacturing hubs to bo...
- Novo Nordisk ties up with Apollo Clinics for obesi...
-
▼
September
(30)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment